Evidence map›Paper›PMID 36993878›Full record

ArticleJournal of molecular structure2023

Synthesis, molecular docking, and binding Gibbs free energy calculation of β-nitrostyrene derivatives: Potential inhibitors of SARS-CoV-2 3CL protease.

Ze-Jun Jia, Xiao-Wei Lan, Kui Lu, Xuan Meng, Wen-Jie Jing, Shi-Ru Jia, Kai Zhao, Yu-Jie Dai

Open access · greenAbstract read
In one paragraph

Article in Journal of molecular structure, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Isovaleryl Sucrose Esters fromMolecules (Basel, Switzerland) · 2024
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ze-Jun JiaCollege of Biotechnology, Tianjin University of Science and Technology, Tianjin, 300457, PR China.
Xiao-Wei LanCollege of Biotechnology, Tianjin University of Science and Technology, Tianjin, 300457, PR China.
Kui LuCollege of Biotechnology, Tianjin University of Science and Technology, Tianjin, 300457, PR China.
Xuan MengCollege of Biotechnology, Tianjin University of Science and Technology, Tianjin, 300457, PR China.
Wen-Jie JingCollege of Biotechnology, Tianjin University of Science and Technology, Tianjin, 300457, PR China.
Shi-Ru JiaCollege of Biotechnology, Tianjin University of Science and Technology, Tianjin, 300457, PR China.
Kai ZhaoHebei Kaisheng Medical Technology Co. LTD, No.319 of Xiangjiang Road, High-tech Zone, Shijiazhuang 050000, PR China.
Yu-Jie DaiCollege of Biotechnology, Tianjin University of Science and Technology, Tianjin, 300457, PR China.
Tianjin University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The outbreak of novel coronavirus disease 2019 (COVID-19), caused by the novel coronavirus (SARS-CoV-2), has had a significant impact on human health and the economic development. SARS-CoV-2 3CL protease (3CLpro) is highly conserved and plays a key role in mediating the transcription of virus replication. It is an ideal target for the design and screening of anti-coronavirus drugs. In this work, seven β-nitrostyrene derivatives were synthesized by Henry reaction and β-dehydration reaction, and their inhibitory effects on SARS-CoV-2 3CL protease were identified by enzyme activity inhibition assay in vitro. Among them, 4-nitro-β-nitrostyrene (compound

Indexed as

3CLpro inhibitorBinding Gibbs free energiesMolecular dockingReceptor-ligand interactionSARS-CoV-2β-nitrostyrene derivatives

Identifiers

PMID36993878
PMCPMC10033154
OpenAlexW4353050220

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.